Nature Medicine, Published online: 27 March 2026; doi:10.1038/s41591-026-04323-8 In the nonpivotal stage 1 of the randomized …
Tag:
Non-Small Cell Lung Cancer
-
-
▲ Photo = Chonbuk National University © Patent News …
-
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer …
-
Nature Medicine, Published online: 04 February 2026; doi:10.1038/s41591-025-04079-7 In the phase 1/2 TRIDENT-1 trial, treatment of …
-
Subcutaneous amivantamab delivered every 4 weeks (Q4W) provides similar efficacy as the intravenous regimen every 2 …
-
Cemiplimab monotherapy provided durable survival benefits compared with chemotherapy for people with advanced non–small cell lung …
-
Uncommon EGFR mutations, such as exon 20 insertions, compound variants, and P-loop αC-helix compressing (Pacc) alterations, …
-
Osimertinib Plus Chemo in EGFR-Mutated NSCLC | Image Credit: © Ashling Wahner & MJH Life Sciences …
-
The FDA granted a breakthrough therapy designation to izalontamab brengitecan (iza-bren, formerly BL-B01D1; Bristol Myers Squibb, …
-
Okay,hear’s the extracted information from the provided text,formatted for better readability: reference 22 Authors: Rios-Doria,J. Title: …
- 1
- 2